Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics

Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics

Ran Chen,1,&ast; Tingting Wang,2,&ast; Jie Song,1,&ast; Daojun Pu,3,&ast; Dan He,1 Jianjun Li,1 Jie Yang,1 Kailing Li,1 Cailing Zhong,1 Jingqing Zhang1 1Chongqing Research Center for Pharmaceutical Engineering, School of Pharmacy, Chongqing Medical University, Chongqing, 400016, Peop...

Full description

Bibliographic Details
Main Authors:	Chen R, Wang T, Song J, Pu D, He D, Li J, Yang J, Li K, Zhong C, Zhang J
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-07-01
Series:	International Journal of Nanomedicine
Subjects:	antiviral drug delivery systems metabolism pharmacokinetics pharmacodynamics
Online Access:	https://www.dovepress.com/antiviral-drug-delivery-system-for-enhanced-bioactivity-better-metabol-peer-reviewed-fulltext-article-IJN

Similar Items

Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version
by: Jiaxi Xie, et al.
Published: (2022-06-01)

Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
by: Julia Koch-Heier, et al.
Published: (2022-06-01)

Pharmacokinetics and Pharmacodynamics: A Comprehensive Analysis of the Absorption, Distribution, Metabolism, and Excretion of Psychiatric Drugs
by: Zainab Zakaraya, et al.
Published: (2024-02-01)

How to use COVID-19 antiviral drugs in patients with chronic kidney disease
by: Ajinath Kale, et al.
Published: (2023-02-01)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
by: Roganović Maša, et al.
Published: (2021-01-01)

The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics
by: Gregory J. Peitz, et al.
Published: (2023-03-01)

Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects
by: Afreen Sultana, et al.
Published: (2022-09-01)

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022-12-01)

Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
by: Kei Xian Tan, et al.
Published: (2023-01-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia
by: Sutep Jaruratanasirikul, et al.
Published: (2015-02-01)

Pharmacokinetics of Chinese medicines: strategies and perspectives
by: Ru Yan, et al.
Published: (2018-05-01)

Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
by: Agata A. Exner, et al.
Published: (2022-08-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
by: Tashinga E. Bapiro, et al.
Published: (2022-07-01)

The pharmacokinetics of phenylbutazone and its interaction with dexamethasone in chicks
by: Sahar K. Abdulhamid, et al.
Published: (2023-01-01)

Re-Assessing PK/PD Issues for Oral Protein and Peptide Delivery
by: Randall J. Mrsny, et al.
Published: (2021-07-01)

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs
by: Tridib Chaira, et al.
Published: (2023-04-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Pharmacodynamics and pharmacokinetics interaction between nefopam and tramadol in the broiler chicks model
by: Yaareb J. Mousa, et al.
Published: (2022-04-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
by: Huixi Zou, et al.
Published: (2020-07-01)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021-10-01)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study
by: Mahvash Iram, et al.
Published: (2016-01-01)

Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
by: Sebastián Scioli Montoto, et al.
Published: (2020-10-01)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
by: Giacomo Luci, et al.
Published: (2021-06-01)

Study on consequences for interaction of myricetin with canagliflozin: A special attention to pharmacokinetics and pharmacodynamics of drug
by: Naga Raju Kandukoori, et al.
Published: (2023-01-01)

Editorial: Pharmacokinetic differences of drugs and their regulatory mechanisms under dual status including normal and diseased organism
by: Zipeng Gong, et al.
Published: (2022-12-01)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
by: Ana Alarcia-Lacalle, et al.
Published: (2021-06-01)

Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses
by: Amal Hammad, et al.
Published: (2023-05-01)

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
by: Taylor Morrisette, et al.
Published: (2020-08-01)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Integration of Enrofloxacin Following Single Oral Administration of Different Doses in Brown Trout (<i>Salmo trutta</i>)
by: Kamil Uney, et al.
Published: (2021-10-01)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
by: Jianbin Min, et al.
Published: (2018-09-01)

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
by: Xiaojiao Li, et al.
Published: (2018-06-01)

Pharmacokinetic—Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
by: Shen Cheng, et al.
Published: (2021-01-01)

Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development
by: Aditya H. Gaur, et al.
Published: (2022-06-01)

A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia
by: Lei Gao, et al.
Published: (2015-01-01)

Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation
by: Badreldin HA, et al.
Published: (2020-07-01)